VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 79 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,616,359 | -69.9% | 208,562 | -55.6% | 0.00% | -70.0% |
| Q2 2023 | $5,373,221 | +940.2% | 469,277 | +600.4% | 0.01% | +900.0% |
| Q1 2023 | $516,547 | -54.0% | 66,997 | -64.7% | 0.00% | -50.0% |
| Q3 2022 | $1,123,000 | -51.8% | 189,736 | -37.9% | 0.00% | -50.0% |
| Q1 2022 | $2,328,000 | +94.8% | 305,445 | -30.9% | 0.00% | +100.0% |
| Q4 2021 | $1,195,000 | +1227.8% | 441,881 | +1922.2% | 0.00% | – |
| Q2 2021 | $90,000 | -41.6% | 21,852 | -33.2% | 0.00% | -100.0% |
| Q1 2021 | $154,000 | -87.3% | 32,695 | -65.9% | 0.00% | -87.5% |
| Q2 2020 | $1,211,000 | -31.9% | 95,954 | -50.7% | 0.01% | -55.6% |
| Q1 2020 | $1,779,000 | +145.4% | 194,444 | +361.4% | 0.02% | +200.0% |
| Q3 2019 | $725,000 | -67.4% | 42,141 | -64.1% | 0.01% | -33.3% |
| Q3 2018 | $2,224,000 | – | 117,498 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,851,507 | $29,849,179 | 1.01% |
| ARMISTICE CAPITAL, LLC | 4,178,000 | $32,379,500 | 0.50% |
| SummerHaven Investment Management, LLC | 72,779 | $564,037 | 0.41% |
| GLOBEFLEX CAPITAL L P | 453,595 | $3,515,361 | 0.41% |
| Ikarian Capital, LLC | 305,857 | $2,370,392 | 0.28% |
| Hillsdale Investment Management Inc. | 367,590 | $2,848,824 | 0.26% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 103,966 | $805,737 | 0.24% |
| Parkman Healthcare Partners LLC | 60,322 | $467,496 | 0.09% |
| Inspire Investing, LLC | 82,656 | $640,584 | 0.08% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 52,500 | $406,875 | 0.08% |